Clinical evaluation and mechanistic research of reinforcing the kidney and eliminating wet combined with platelet-rich plasma in the treatment of earlier period of knee oseoarthritis.

Wangjing Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet the diagnostic criteria of western or Traditional Chinese medicine for knee osteoarthritis;
•2. It meets the requirements for the indications of the diagnosis and treatment technology studied;
•3. Compliance with Kellgren-lawrance X-ray classification level 0, Level I and Level II;
•4. Sign the informed consent.

•1. Patients who do not meet the diagnostic criteria and inclusion criteria for knee osteoarthritis.
•2. Those who have received other relevant treatments, which may affect the effect indicators in this study.
•3. Patients with life-threatening primary diseases such as cardiovascular and cerebrovascular diseases, liver and kidney diseases and mental diseases.
•4. Exclude research diseases:
•(1) rheumatic diseases: rheumatoid arthritis, ankylosing spondylitis, etc.;
•(2) Infectious arthritis: joint tuberculosis, purulent arthritis, etc.;
•(3) Reactive arthritis: allergic arthritis, thrombocytopenic purpura arthritis;
•(4) Metabolic joint diseases: Kashin-beck disease, gout, etc.;
•(5) Intra-articular tumor;
•(6) Other specific joint diseases.

发起方

Wangjing Hospital, China Academy of Chinese Medical Sciences